Related Experiment Video

Updated: Jun 25, 2025

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa
13:40

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa

Published on: February 17, 2014

11.9K

Antibiotic influx and efflux in Pseudomonas aeruginosa: Regulation and therapeutic implications

Weiyan Wu1, Jiahui Huang1, Zeling Xu1

  • 1Guangdong Province Key Laboratory of Microbial Signals and Disease Control, Integrative Microbiology Research Centre, South China Agricultural University, Guangzhou, China.

Microbial Biotechnology
|May 27, 2024
PubMed

Insights

Pseudomonas aeruginosa, a multidrug-resistant pathogen, develops resistance through porin and efflux pump regulation. Targeting these mechanisms offers new therapeutic strategies against challenging infections.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Pseudomonas aeruginosa is a major multidrug-resistant pathogen causing significant global health concerns.
  • Antibiotic resistance in P. aeruginosa is driven by complex regulatory networks controlling porin and efflux pump expression.
  • Treating P. aeruginosa infections is difficult due to its highly inducible resistance mechanisms.

Purpose of the Study:

  • To comprehensively review the regulatory networks of key porin proteins and efflux pumps in P. aeruginosa.
  • To discuss therapeutic strategies for enhancing antibiotic efficacy by targeting these resistance mechanisms.
  • To highlight the complexity of P. aeruginosa's inducible resistance and its therapeutic implications.

Main Methods:

  • Literature review of regulatory networks governing porin and efflux pump systems.
  • Analysis of molecular signals and mutational changes influencing resistance.
  • Discussion of novel therapeutic adjuvants targeting resistance mechanisms.

Main Results:

  • Detailed summary of regulatory networks for major porins (OprD, OprH) and efflux pumps (MexAB-OprM, MexCD-OprJ, MexEF-OprN, MexXY).
  • Identification of downregulated influx and upregulated efflux as key resistance strategies.
  • Elucidation of the inducible nature of antibiotic resistance in P. aeruginosa.

Conclusions:

  • The intricate regulatory networks controlling porin and efflux pump expression are central to P. aeruginosa's multidrug resistance.
  • Targeting these inducible mechanisms with novel adjuvants presents a promising therapeutic avenue.
  • Understanding these pathways is crucial for developing effective treatments against resistant P. aeruginosa infections.

More Related Videos

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

33.0K
Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

12.7K

Related Concept Videos

Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.3K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
365
Antibiotic Selection00:57

Antibiotic Selection

Overview
53.2K
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
47
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
175
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
54